Source: biospectrumindia

DiabetOmics: DiabetOmics set to sprawl in Hyderabad

US-based DiabetOmics Inc, which has set up a facility to manufacture rapid testing kits (including one for saliva-based diabetes monitoring) on Hyderabad’s outskirts at Mupireddipally in Medak district, is planning to raise about $20 million early next year to fund the commercialisation of its products and expansion of its recently commissioned global facility in Hyderabad.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Srinivasa Nagalla's photo - President & CEO of Diabetomics

President & CEO

Srinivasa Nagalla

CEO Approval Rating

87/100

Read more